Skip to main content

Table 1 Demographics of XP Patients with Nerve Conduction Studies

From: Differences in peripheral neuropathy in xeroderma pigmentosum complementation groups A and D as evaluated by nerve conduction studies

 

Complementation Group

XP-A

XP-C

XP-D

XP-E

XP-V

XP unk

Number

9

7

10

1

4

2

Mean Age ± Std Dev

16.7 ± 9.0

13.1 ± 6.9

18.5 ± 2.1

42

43.5 ± 9.1

12, 36

(Range)

(3–24)

(5–25)

(5–43)

(34–54)

Sex (F:M)

5:4

4:3

4:6

1:0

3:1

1:1

Abn SNCS

7/9

0/7

5/10

0/1

0/4

0/2

Abn MNCS

7/9

0/7

0/10

0/1

0/4

0/2

Abn Hearing

6/8

0/6

5/10

0/1

0/3

0/1

Abn MRI/CT

7/8

0/4

6/8

  

0/1

Abn IQ

5/6

0/4

3/6

  

0/1

  1. Abbreviations: XP-A Xeroderma pigmentosum complementation group A, XP-C Xeroderma pigmentosum complementation group C, XP-D Xeroderma pigmentosum complementation group D, XP-E Xeroderma pigmentosum complementation group E, XP-V Xeroderma pigmentosum variant, XP unk Xeroderma pigmentosum – Unknown mutation, F Female, M Male, Abn Abnormal, SNCS Sensory nerve conduction studies, MNCS Motor nerve conduction studies (fibular nerve), MRI Magnetic resonance imaging, CT Computed tomography, IQ Intelligence quotient, Std dev Standard deviation
Back to article page

BMC Neurology

ISSN: 1471-2377

Contact us